Company news

Cynata Therapeutics Limited news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Cyanta & Celularity Inc Execute MOU

January 22, 2018

Encouraging Early Data-Cynata Clinical Trial Proceeds

January 21, 2018

Final Preclinical Asthma Study Confirms Efficacy

December 11, 2017

United States Patent Allowance for Core Cynata Technology

December 7, 2017

Enrolment Completed in 1st Cohort of Cynata Clinical Trial

November 14, 2017

September 2017 Quarterly Report

October 27, 2017

Notice of Annual General Meeting/Proxy Form

October 9, 2017

Cynata to Increase Exposure in Japan

October 8, 2017

US Patent Granted for Cynata Cymerus Technology

September 27, 2017

Health Canada Meeting Advances CYP Global Development Plans

August 31, 2017

Positive Data from CYP MSCs in 2nd Preclinical Asthma Study

August 23, 2017

June 2017 Quarterly Report

July 28, 2017

FDA Meeting Provides Clear Path for US Development Plans

July 4, 2017

Cynata Therapeutics GvHD Clinical Trial & Corporate Progress

June 27, 2017

CYP MSC Data in Asthma Model Published in Sceintific Journal

June 22, 2017

Cynata Files New Patent Application for Cymerus in Oncology

June 20, 2017

United States Patent for Core Cynata Technology

June 19, 2017

Treatment Commences in Cynatas World First Clinical Trial

May 16, 2017

March 2017 Quarterly Report

April 26, 2017

Cynata Advances to Pre-IND Meeting with US FDA

April 18, 2017

CYP Files for New Patent for Oncology Applications

April 12, 2017

CYP in Collaboration on Acute Respiratory Distress Syndrome

April 10, 2017

Cynata Partner apceth GmbH & Co Completes Cymerus Evaluation

March 30, 2017

CYP Advances Development of Cymerus for Treatment of Asthma

March 1, 2017

Final GvHD Preclinical Report Confirms Treatment Benefit

February 5, 2017

Positive Preliminary Data from Preclinical HeartAttack Study

February 1, 2017

Appendix 4C - quarterly

January 25, 2017

Cynata Successfully Completes Capital Raising

January 22, 2017

Cynata & FUJIFILM Sign Strategic Partnership Agreement

January 18, 2017

Cynatas Clinical Study Approved in Austrralia

December 15, 2016

Cynata Receives NHS HRA Approval for Clinical Study

December 12, 2016

Cynata Files Further Patent Application

November 28, 2016

Cynata Receives $1.749m R&D Tax Incentive Refund

November 15, 2016

Activities Report & Appendix 4C

October 31, 2016

Efficacy for CYP MSC Technology in Preclinical Asthma Study

October 16, 2016

UK Regulatory Authority Approves Cynata GvHD Clinical Trial

September 19, 2016

CYP Determines not to proceed with Regience Investment Offer

September 5, 2016

CYP & FUJIFILM Sign Non-Binding Terms Sheet

September 4, 2016

Cynata Files Application to Commence Phase 1 Clinical Trial

July 31, 2016

Cynata Receives Investment Offer from Regience

June 30, 2016

Cynata Prepares for Phase 1 Clinical Trial

June 20, 2016

Cynata Enters Agreement with apceth GmbH & Co KG

May 8, 2016

CYP Manufactures CT Product-Files Further Patent Application

May 5, 2016

Decision to Grant Patent for Cymerus MSC Technology in Japan

May 2, 2016

Cynata & Regience Extend Entitlement Period

April 29, 2016

Compelling Results from Pre-Clinical Stem Cell Study in GvHD

April 6, 2016

Cynata Announces Landmark Licensing Deal

March 30, 2016

Cynata Enters Agreement for Strategic Alliance in Japan

March 3, 2016

Cynata Receives $930k R&D Tax Incentive Refund

February 15, 2016

Quarterly Activities Report & Appendix 4C

February 11, 2016

← Newer news releases · Older news releases →

Decks

The 5 newest of 39 decks. Every deck is listed under its year.